Publications in collaboration with researchers from John Radcliffe Hospital (60)

2024

  1. Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy: Lessons from SYNTAX II and Beyond

    Cardiology Clinics, Vol. 42, Núm. 1, pp. 147-158

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Adeno-associated virus 2 infection in children with non-A–E hepatitis

    Nature, Vol. 617, Núm. 7961, pp. 555-563

  3. Coronary Physiology as Part of a State-of-the-Art Percutaneous Coronary Intervention Strategy: Lessons from SYNTAX II and Beyond

    Interventional Cardiology Clinics, Vol. 12, Núm. 1, pp. 141-153

  4. Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry

    European Journal of Neurology, Vol. 30, Núm. 2, pp. 399-412

  5. Genomic investigations of unexplained acute hepatitis in children

    Nature, Vol. 617, Núm. 7961, pp. 564-573

  6. Ravulizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

    Annals of Neurology, Vol. 93, Núm. 6, pp. 1053-1068

2022

  1. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997

  2. Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension

    Multiple Sclerosis Journal, Vol. 28, Núm. 3, pp. 480-486

  3. Extended Coagulation Profiling in Isolated Traumatic Brain Injury: A CENTER-TBI Analysis

    Neurocritical Care, Vol. 36, Núm. 3, pp. 927-941

  4. Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study

    European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316

  5. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy

    Circulation. Arrhythmia and electrophysiology, Vol. 15, Núm. 5, pp. e010075

  6. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy

    European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653

2021

  1. Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

    Annals of Neurology, Vol. 89, Núm. 6, pp. 1088-1098

  2. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749

  3. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

    Journal of the American Society of Nephrology, Vol. 32, Núm. 2

2020

  1. Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders

    American Journal of Geriatric Psychiatry, Vol. 28, Núm. 4, pp. 410-420

  2. Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A sub-analysis of the SYNTAX II study

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 1, pp. 10-17

2019

  1. A universal right to pain relief: balancing the risks in a vulnerable patient population

    The Lancet Child and Adolescent Health

  2. Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 3, pp. 259-270